Can Cytoreductive Nephrectomy Improve Outcomes of Nivolumab Treatment in Patients with Metastatic Clear-Cell Renal Carcinoma?

Autor: Ocak B; Department of Medical Oncology, Bursa Yuksek Ihtisas Training and Research Hospital, University of Health Sciences, Bursa 16350, Turkey., Sahin AB; Department of Medical Oncology, School of Medicine, Bursa Uludag University, Bursa 16059, Turkey., Ertürk I; Department of Medical Oncology, Gulhane School of Medicine, University of Health Sciences, Ankara 06018, Turkey., Korkmaz M; Department of Medical Oncology, School of Medicine, Necmettin Erbakan University, Konya 42090, Turkey., Erdem D; Department of Medical Oncology, VM Medical Park Samsun Hospital, Samsun 55200, Turkey., Cakıroglu U; Department of Medical Oncology, Van Training and Research Hospital, University of Health Sciences, Van 65300, Turkey., Karaca M; Department of Medical Oncology, Antalya Training and Research Hospital, University of Health Sciences, Antalya 07100, Turkey., Dirican A; Department of Medical Oncology, School of Medicine, Celal Bayar University, Manisa 45140, Turkey., Olmez OF; Department of Medical Oncology, Medipol University Hospital, Istanbul 34810, Turkey., Goktas Aydın S; Department of Medical Oncology, Medipol University Hospital, Istanbul 34810, Turkey., Gökyer A; Department of Medical Oncology, Department of Internal Medicine, School of Medicine, Trakya University, Edirne 22130, Turkey., Kücükarda A; Department of Medical Oncology, Department of Internal Medicine, School of Medicine, Trakya University, Edirne 22130, Turkey., Gülmez A; Department of Medical Oncology, School of Medicine, Inonu University, Malatya 44280, Turkey., Yumuk PF; Department of Medical Oncology, School of Medicine, Marmara University, Istanbul 34854, Turkey., Demircan NC; Department of Medical Oncology, School of Medicine, Marmara University, Istanbul 34854, Turkey., Oyman A; Department of Medical Oncology, Umraniye Training and Research Hospital, University of Health Sciences, Istanbul 34764, Turkey., Sakalar T; Department of Medical Oncology, Necip Fazıl City Hospital, Kahramanmaraş 46050, Turkey., Karatas F; Department of Medical Oncology, Faculty of Medicine, Karabuk University, Karabuk 78100, Turkey., Demir H; Department of Medical Oncology, Afyonkarahisar Health Sciences University, Afyon 03030, Turkey., Yasin AI; Department of Medical Oncology, Faculty of Medicine, Bezmialem Vakif University, Istanbul 34093, Turkey., Deligonul A; Department of Medical Oncology, School of Medicine, Bursa Uludag University, Bursa 16059, Turkey., Dakiki B; Department of Medical Oncology, School of Medicine, Bursa Uludag University, Bursa 16059, Turkey., Goktug MR; Department of Medical Oncology, School of Medicine, Bursa Uludag University, Bursa 16059, Turkey., Avcı O; Department of Medical Oncology, Tekirdağ Namık Kemal University, Tekirdağ 34093, Turkey., Tacar SY; Department of Medical Oncology, Tekirdağ Namık Kemal University, Tekirdağ 34093, Turkey., Turhal NS; Department of Medical Oncology, Anadolu Health Center, Kocaeli 2255, Turkey., Deniz GI; Department of Medical Oncology, Sisli Hamidiye Etfal Training and Research Hospital, University of Health Sciences, Istanbul 34371, Turkey., Kacan T; Department of Medical Oncology, Bursa Yuksek Ihtisas Training and Research Hospital, University of Health Sciences, Bursa 16350, Turkey., Cubukcu E; Department of Medical Oncology, School of Medicine, Bursa Uludag University, Bursa 16059, Turkey., Evrensel T; Department of Medical Oncology, School of Medicine, Bursa Uludag University, Bursa 16059, Turkey.

Publikováno v: Current oncology (Toronto, Ont.) [Curr Oncol] 2024 Sep 04; Vol. 31 (9), pp. 5195-5205. Date of Electronic Publication: 2024 Sep 04.

Lutetium-Associated Myopathy: A Case Report.

Autor: Gulturk I; Medical Oncology Department, Bakırkoy Sadi Konuk Training and Research Hospital, Istanbul, Turkey., Sonmezoz GB; Internal Medicine Department, Bakırkoy Sadi Konuk Training and Research Hospital, Istanbul, Turkey., Yilmaz M; Medical Oncology Department, Bakırkoy Sadi Konuk Training and Research Hospital, Istanbul, Turkey., Tacar SY; Medical Oncology Department, Bakırkoy Sadi Konuk Training and Research Hospital, Istanbul, Turkey., Ozmen A; Medical Oncology Department, Bakırkoy Sadi Konuk Training and Research Hospital, Istanbul, Turkey., Erdal GS; Medical Oncology Department, Bakırkoy Sadi Konuk Training and Research Hospital, Istanbul, Turkey., Nalbant MO; Radiology Department, Bakırkoy Sadi Konuk Training and Research Hospital, Istanbul, Turkey., Tural D; Medical Oncology Department, Bakırkoy Sadi Konuk Training and Research Hospital, Istanbul, Turkey.

Publikováno v: American journal of therapeutics [Am J Ther] 2024 Jan-Feb 01; Vol. 31 (1), pp. e81-e84. Date of Electronic Publication: 2022 Mar 24.

Decrease in estimated glomerular filtration rates in non-small cell lung cancer patients treated with crizotinib.

Autor: Iriagac Y; Department of Medical Oncology, Faculty of Medicine, Tekirdag Namik Kemal University, Tekirdag, Turkey., Cavdar E; Department of Medical Oncology, Faculty of Medicine, Tekirdag Namik Kemal University, Tekirdag, Turkey., Karaboyun K; Department of Medical Oncology, Faculty of Medicine, Tekirdag Namik Kemal University, Tekirdag, Turkey., Tacar SY; Department of Medical Oncology, Dr. Sadi Konuk Training and Research Hospital, Istanbul, Turkey., Akkoc Mustafayev FN; Department of Medical Oncology, Faculty of Medicine, University of Health Sciences Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey., Celik E; Department of Medical Oncology, Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey., Avci O; Department of Medical Oncology, Faculty of Medicine, Tekirdag Namik Kemal University, Tekirdag, Turkey., Okutur SK; Department of Medical Oncology, Memorial Bahçelievler Hospital, Istanbul, Turkey., Koral L; Department of Oncology, Canakkale Onsekiz Mart University, Faculty of Medicine, Çanakkale, Turkey., Demirci NS; Department of Medical Oncology, Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey., Ozgun A; Department of Medical Oncology, Faculty of Medicine, University of Health Sciences Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey., Seber ES; Department of Medical Oncology, Faculty of Medicine, Tekirdag Namik Kemal University, Tekirdag, Turkey.

Publikováno v: Journal of cancer research and therapeutics [J Cancer Res Ther] 2023 Jan-Mar; Vol. 19 (2), pp. 376-381.

Crizotinib for c-MET -amplified advanced NSCLC: a single-center experience.

Autor: Tacar SY; Medical Oncology Department, Bakırköy Sadi Konuk Training and Research Hospital, Istanbul, Turkey., Yilmaz M; Medical Oncology Department, Bakırköy Sadi Konuk Training and Research Hospital, Istanbul, Turkey., Oz B; Pathology Department, Istanbul University-Cerrahpaşa, Istanbul, Turkey., Tural D; Medical Oncology Department, Bakırköy Sadi Konuk Training and Research Hospital, Istanbul, Turkey.

Publikováno v: Tumori [Tumori] 2022 Jun; Vol. 108 (3), pp. 258-262. Date of Electronic Publication: 2021 Apr 13.

Thirty-day mortality rates after immunotherapy initiation.

Autor: Sütcüoğlu O; Gazi University, Department of Medical Oncology, Ankara, Turkey., İlhan A; Dr. Abdurrahman Yurtaslan Ankara Oncology Training & Research Hospital, Department of Medical Oncology, Ankara, Turkey., Tacar SY; Dr. Sadi Konuk Training & Research Hospital, Department of Medical Oncology, Istanbul, Turkey., Güven DC; Hacettepe University Cancer Institute, Department of Medical Oncology, Ankara, Turkey., Uçar G; Health of Science Ankara City Hospital, Department of Medical Oncology, Ankara, Turkey., Karadurmuş N; Health Sciences University Gulhane Training & Research Hospital, Department of Medical Oncology, Ankara, Turkey., Yıldız F; Dr. Abdurrahman Yurtaslan Ankara Oncology Training & Research Hospital, Department of Medical Oncology, Ankara, Turkey., Eraslan E; Dr. Abdurrahman Yurtaslan Ankara Oncology Training & Research Hospital, Department of Medical Oncology, Ankara, Turkey., Uncu D; Health of Science Ankara City Hospital, Department of Medical Oncology, Ankara, Turkey., Tural D; Dr. Sadi Konuk Training & Research Hospital, Department of Medical Oncology, Istanbul, Turkey., Üner A; Gazi University, Department of Medical Oncology, Ankara, Turkey., Günel N; Gazi University, Department of Medical Oncology, Ankara, Turkey., Özdemir N; Gazi University, Department of Medical Oncology, Ankara, Turkey., Kılıçkap S; Hacettepe University Cancer Institute, Department of Medical Oncology, Ankara, Turkey., Öksüzoğlu ÖB; Dr. Abdurrahman Yurtaslan Ankara Oncology Training & Research Hospital, Department of Medical Oncology, Ankara, Turkey., Özet A; Gazi University, Department of Medical Oncology, Ankara, Turkey., Yazıcı O; Gazi University, Department of Medical Oncology, Ankara, Turkey.

Publikováno v: Immunotherapy [Immunotherapy] 2021 Dec; Vol. 13 (17), pp. 1419-1426. Date of Electronic Publication: 2021 Oct 22.